You are here: Industry Insights > acquisition

News List

Sterling Pharma Solutions Acquires ADC Biotechnology contractpharma
April 08, 2021
Global contract development and manufacturing organization (CDMO), Sterling Pharma Solutions, has acquired ADC Biotechnology, a UK-based bioconjugation development services business specializing in antibody drug conjugates (ADCs).
Amneal completes acquisition of Kashiv Specialty Pharmaceuticals expresspharma
April 06, 2021
Kashiv Specialty Pharmaceuticals is focused on the development of complex generics, innovative drug delivery platforms and novel 505(b)(2) drugs.
Charles River Acquires Retrogenix contractpharma
April 06, 2021
Charles River Laboratories has acquired early-stage contract research organization (CRO) Retrogenix, a provider of specialized bioanalytical services utilizing its proprietary cell microarray technology, for $48 million.
Eloxx Pharmaceuticals Acquires Zikani Therapeutics contractpharma
April 02, 2021
Eloxx Pharmaceuticals, Inc. has acquired Zikani Therapeutics, Inc. in an all-stock transaction, combines complementary ribosomal RNA-targeted genetic therapy platforms and therapies for the treatment of rare diseases and oncology.
Servier Acquires Agios Pharmaceuticals’ Oncology Portfolio contractpharma
April 02, 2021
Servier, a global pharmaceutical company, has successfully completed its acquisition of Agios Pharmaceuticals' commercial, clinical and research-stage oncology portfolio for up to $2 billion plus royalties.
Natco Pharma board okays acquiring 1 per cent in Canadian arm expresspharma
March 29, 2021
The board of directors of the company at their meeting approved to acquire 0.96 per cent stake in Natco Pharma Canada.
Romaco Acquires STE Tecpharm contractpharma
March 19, 2021
Strengthens Romaco’s processing business with Tecpharm’s drum coaters, coupled with conventional granulation lines and Wurster fluid bed systems.
WuXi Biologics to Acquire Manufacturing Facilities from Pfizer China contractpharma
March 18, 2021
WuXi Biologics has entered into an equity agreement with Pfizer China to acquire its state-of-the-art biologics manufacturing facilities as well as its labor force in Hangzhou, China.
Sotera Health Announces Acquisition of Montana-Based BioScience Laboratories americanpharmaceuticalreview
March 15, 2021
Sotera Health has acquired Montana-based BioScience Laboratories. This acquisition expands the US-based antimicrobial and antiviral testing capabilities of Sotera Health’s Nelson Labs business. Terms of the deal were not disclosed.
Takeda exercises option to acquire Maverick Therapeutics for $525m pharmaceutical-technology
March 11, 2021
Takeda Pharmaceutical Company has exercised its option to acquire Maverick Therapeutics for a pre-negotiated upfront payment and potential development and regulatory milestones totalling up to $525m.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page